Expertise in
1
conditions

Dr. Christina Migliore

Intensive Care Medicine
Newark Beth Israel Medical Center
201 Lyons Ave # 16, 
Newark, NJ 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
1
conditions
Newark Beth Israel Medical Center
201 Lyons Ave # 16, 
Newark, NJ 

Overview

Christina Migliore is an Intensive Care Medicine provider practicing medicine in Newark, New Jersey.

Dr. Migliore is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Systemic Sclerosis (SSc), Emphysema, and Lung Nodules.

She is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 5 clinical trials. Dr. Migliore is currently accepting new patients.

Specialties

Intensive Care Medicine

Licenses

Internal Medicine in NJ

Hospital Affiliations

Newark Beth Israel Medical Center
Cooperman Barnabas Medical Center
Jfk University Medical Center
Robert Wood Johnson University Hospital At Rahway

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Newark Beth Israel Medical Center
201 Lyons Ave # 16, Newark, NJ 07112

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Drug
Study Drug: UT-15C
Study Phase: Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

3 Total Publications

Fungemia in COVID-19 ICU patients, a single medical center experience.
Fungemia in COVID-19 ICU patients, a single medical center experience.
Journal: Journal of medical virology
Published: August 27, 2020
Similar Doctors
Expertise in
27
conditions
Dr. Dany E. Elsayegh
Intensive Care Medicine | Sleep Medicine | Pulmonary Medicine
Expertise in
27
conditions
Dr. Dany E. Elsayegh
Intensive Care Medicine | Sleep Medicine | Pulmonary Medicine
Referral may be required
Before you request

Northwell Health Physician Partners Pulmonary Medicine At Seaview Avenue

501 Seaview Avenue, Suite 102, 
Staten Island, NY 
 (11.0 miles away)
718-980-5700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dany Elsayegh is an Intensive Care Medicine specialist and a Sleep Medicine provider practicing medicine in Staten Island, New York. Dr. Elsayegh is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Asthma, Asthma in Children, Lung Metastases, Gastrostomy, and Tissue Biopsy. Dr. Elsayegh is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Critical Care Medicine, American Board Of Internal Medicine/Pulmonary Disease, and American Board Of Internal Medicine/Sleep Medicine. Dr. Elsayegh is currently accepting new patients.

Expertise in
3
conditions
Dr. Stavros G. Memtsoudis
Intensive Care Medicine
Expertise in
3
conditions
Dr. Stavros G. Memtsoudis
Intensive Care Medicine
Referral may be required

Hospital For Special Surgery

535 E 70th St, 
New York, NY 
 (14.0 miles away)
212-606-1206
Languages Spoken:
English

Stavros Memtsoudis is an Intensive Care Medicine provider practicing medicine in New York, New York. Dr. Memtsoudis is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Cervical Myelopathy, Venous Thromboembolism (VTE), Knee Replacement, and Hip Replacement.

Expertise in
18
conditions
Dr. Peter M. Gottlieb
Intensive Care Medicine | Pulmonary Medicine
Expertise in
18
conditions
Dr. Peter M. Gottlieb
Intensive Care Medicine | Pulmonary Medicine
Referral may be required
Before you request
2905 Hylan Boulevard, 
Staten Island, NY 
 (11.2 miles away)
718-351-1212
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Peter Gottlieb is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Staten Island, New York. Dr. Gottlieb is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Asthma in Children, and Asthma. Dr. Gottlieb is currently accepting new patients.

Frequently Asked Questions about Dr. Christina Migliore

How do I make an appointment with Dr. Christina Migliore?

You can book an appointment with Dr. Christina Migliore by calling their office at 201-467-8351. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Christina Migliore a top-rated expert for Pulmonary Fibrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christina Migliore is classified as an Advanced expert for Pulmonary Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Christina Migliore specialize in?

While Dr. Christina Migliore is a Intensive Care Medicine, they have specific expertise in Pulmonary Fibrosis, Systemic Sclerosis (SSc), and Emphysema. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.

Does Dr. Christina Migliore participate in research or clinical trials?

Yes. Dr. Christina Migliore has published 3 articles and abstracts on conditions like Pulmonary Fibrosis. You can view a list of Dr. Christina Migliore's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Christina Migliore accept my insurance?

Dr. Christina Migliore accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 201-467-8351 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Migliore's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile